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Linda Johansson1†, Natalia Sherina2†, Nastya Kharlamova2, Barbara Potempa3, Barbro Larsson2, Lena Israelsson2,
Jan Potempa3,4, Solbritt Rantapää-Dahlqvist1*† and Karin Lundberg2†Erratum
Unfortunately, after publication of this article [1], it was
noticed that the x-axis markers for Fig. 2a and b were
incorrect. The corrected figure can be seen below.
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Fig. 2 Antibody responses during the pre-dating time until the time point for onset of symptoms of RA, from pre-symptomatic individuals who donated
multiple blood samples pre-dating the onset of symptoms of RA (n= 422) and from patients with RA (n= 192). Logarithmic mean concentrations during
2-year periods of anti-RgpB and anti-CPP3 antibodies in pre-symptomatic individuals, patients with RA and controls (n= 198) (a). Accumulated percentages
of antibody positivity for anti-CPP3, anti-CCP2, anti-cfibrinogenβ36-52 (cFibβ36-52), anti-CEP-1 (α-enolase) and anti-cfilaggrin (cFilaggrin) antibodies in
pre-symptomatic individuals and in patients with RA (b). 0 time point for onset of RA symptoms
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